Drug
Iodine I 131 Moab 8h9
Iodine I 131 Moab 8h9: highest development phase Phase 1, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Iodine I 131 MOAB 8H9 NCT00089245 | Phase 1 | Brain and Central Nervous System Tumors |
Latest
No recent events.
Follow Iodine I 131 Moab 8h9 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.